Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

By now you should have received your copy of Pharmacy Compounding Leader, the first issue of our new newsletter showcasing the updated Pharmacy Compounding Professional’s Code of Ethics.

The actions of any compounder reflect on every compounder. That’s why our focus on ethical behavior: teaching, reinforcing, and showcasing.

Pharmacy Compounding Leader is that latter, with five examples of APC members who demonstrate the kind of ethical behavior, patient commitment, and community connection that reflect well on all of us.

Take a few minutes to read it and appreciate what those folks have done — and think about the big and little ways you can take their examples to heart, every day. (Lost your paper copy? Click here to read or download it.)